国浩律师（北京）事务所 关于 福建万辰生物科技集团股份有限公司 2024 年第六次临时股东大会 之 法律意见书 北京市朝阳区东三环北路 38 号泰康金融大厦 9 层 邮编：100026 9 th Floor, Taikang Financial Tower, No. 38 North Road East Third Ring, Chaoyang District, Beijing, 100026, China 电话/Tel: 010-65890699 传真/Fax: 010-65176800 网址/Website: http://www.grandall.com.cn 2024 年 11 月 国浩律师（北京）事务所 法律意见书 国浩律师（北京）事务所 关于福建万辰生物科技集团股份有限公司 2024 年第六次临时股东大会之 法律意见书 国浩京证字【2024】第 0412 号 致：福建万辰生物科技集团股份有限公司 国浩律师（北京）事务所接受福建万辰生物科技集团股份有限公司（以下简 称"公司"或"万辰集团"）的委托，指派律师出席并见证了公司 2024 年 11 月 11 日召开的 2024 年第六次临时股东大会（以 ...

证券代码：300972 证券简称：万辰集团 公告编号：2024-103 福建万辰生物科技集团股份有限公司 关于 2022 年限制性股票激励计划首次授予部分第二个归属期及 预留授予部分第一个归属期归属结果暨股份上市的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 重要内容提示： 1、符合本次第二类限制性股票归属条件的激励对象共计 51 人，鉴于在实际 办理归属过程中，7 名激励对象暂缓归属，因此本次实际归属人数为 44 人，其 中首次授予部分激励对象 39 人，预留授予激励对象 5 人。 2、本次第二类限制性股票归属数量：50.4829 万股，占当前公司总股本的 0.2813%（其中首次授予部分第二个归属期第二类限制性股票拟归属数量： 44.3419 万股，预留授予部分第一个归属期第二类限制性股票拟归属数量：6.1410 万股） 3、本次归属的限制性股票来源：公司向激励对象定向发行的本公司人民币 A 股普通股股票 4、本次归属的限制性股票上市流通日为 2024 年 11 月 11 日 根据福建万辰生物科技集团股份有限公司（以下简称"公司"或"万辰集团"） ...

证 报 公 司 研 2024 年 11 月 04 日 究 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------|-------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

欢迎加入会议会议系统请输入参会密码并以请号键结束您拨入的号码显号为023-6273-7263此号码没有在白名单内请联系相关对接人 添加此选号到白名单您拨入的号码选号为023-6273-7263此号码没有在白名单内请联系相关对接人添加此选号到白名单您拨入的号码选号为023-6273-7263此号码没有在白名单内请联系相关对接人添加此选号到白名单 欢迎介入智能财经电话会议系统请输入参会密码您已成功加入会议感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后感谢大家参加本次会议会议即将开始 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后感谢大家参加本次会议会议即将开始 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后感谢大家参加本次会议会议即将开始 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后 感谢大家参加本次会议会议即将开始请稍后感谢大 ...

[Table_Title] 加速拓店，规模效应下盈利逐步释放 300972）2024 年三季报点评 | --- | --- | --- | |-----------------------|-----------------------------------------|--------------| | 2024 | 年 11 月 01 日 | 公司研究 | | 研究所： 证券分析师： | 刘洁铭 S0350521110006 liujm@ghzq.com.cn | | | 证券分析师： | 秦一方 S0350523120001 qinyf@ghzq.com.cn | ——万辰集团（ | 评级：增持(首次覆盖) 事件: 最近一年走势 2024 年 10 月 29 日，万辰集团发布 2024 年三季报。公司 2024 年 Q1-3 实现营收 206.13 亿元，同比+320.63%；归母净利润 0.84 亿元，同比 +248.64%；扣非归母净利润 0.76 亿元，同比+221.48%。公司 2024Q3 实现营收 96.98 亿元，同比+261.32%；归母净利润 0.83 亿元，同比 +263.06%； ...

| --- | --- | --- | |----------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300972 证券简称：万辰集团 公告编号：2024-099 二、监事会会议审议情况 全体与会监事经认真审议，形成以下决议： （一）审议通过《关于公司<2024 年第三季度报告>的议案》 经审议，监事会认为：公司《2024 年第三季度报告》的编制和审核程序符合 相关法律、法规的要求，报告内容真实、准确、完整地反映了公司 2024 年第三 季度经营的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司披露于巨潮资讯网（www.cninfo.com.cn）的《2024 年第 三季度报告》。 福建万辰生物科技集团股份有限公司 第四届监事会第二十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 福建万辰生物科技集团股份有限公司（以下简称"公司"）第四届监事会第 二十一次会议于 2024 年 10 月 28 日在公司会议室以现场结合通讯方式召开，本 次监事会会议通知于 2024 年 10 月 25 日以书面、电子邮件的形式向公司全体监 事发出。会议应参与表决监事 3 名，实际参与表决监事 3 名，会议由 ...

Financial Performance - Revenue for the third quarter reached 9.70 billion yuan, a year-on-year increase of 261.32%[3] - Net profit attributable to shareholders of the listed company was 83.13 million yuan, up 263.06% year-on-year[3] - Revenue for the first nine months of 2024 increased by 320.63% to 20.61 billion yuan, driven by the expansion of the company's snack retail business[9] - Net profit for the first nine months of 2024 surged by 352.09% to 344.68 million yuan, with the snack retail business contributing 392 million yuan in net profit[10] - Total revenue for the period reached 20,613,100,328.64 yuan, a substantial increase from 4,900,487,114.84 yuan in the same period last year[22] - Operating profit for the quarter was 582.94 million yuan, compared to a loss of 129.50 million yuan in the same period last year[23] - Net profit attributable to the parent company's shareholders was 84.07 million yuan, an improvement from a loss of 56.56 million yuan in the previous year[23] - Total comprehensive income for the period was 344.68 million yuan, compared to a loss of 136.73 million yuan in the previous year[24] - Basic earnings per share were 0.5001 yuan, compared to a loss of 0.3684 yuan in the same period last year[24] Cash Flow and Financial Position - Operating cash flow for the period was 972.48 million yuan, a significant increase of 1,696.18% year-on-year[3] - Operating cash flow for the first nine months of 2024 increased by 1696.18% to 972.48 million yuan, primarily due to increased cash inflows from the expanded snack retail business[11] - The company's investment activities resulted in a net cash outflow of 370.58 million yuan, a 203.26% increase, primarily due to payments for equity acquisitions[11] - The company's financing activities generated a net cash inflow of 455.06 million yuan, a 51.03% increase, driven by equity financing and increased bank borrowings[11] - Operating cash flow for the quarter was RMB 972.48 million, compared to a negative RMB 60.93 million in the same period last year[26] - Total cash outflow from operating activities was RMB 22.84 billion, a significant increase from RMB 5.82 billion in the previous year[26] - Cash paid for goods and services reached RMB 21.52 billion, up from RMB 5.14 billion year-over-year[26] - Cash paid for employee compensation and benefits was RMB 572.45 million, compared to RMB 260.82 million in the same period last year[26] - Net cash used in investing activities was RMB 370.58 million, compared to RMB 122.20 million in the previous year[26] - Cash inflow from financing activities totaled RMB 1.07 billion, up from RMB 438.43 million year-over-year[26] - Net cash inflow from financing activities was RMB 455.06 million, compared to RMB 301.30 million in the same period last year[26] - The company's cash and cash equivalents at the end of the quarter stood at RMB 2.21 billion, a significant increase from RMB 233.21 million at the end of the previous year[26] Assets and Liabilities - Total assets as of the end of the reporting period were 6.46 billion yuan, an increase of 64.53% compared to the end of the previous year[3] - Inventory increased by 143.77% to 1.79 billion yuan due to the expansion of the discount snack business[7] - Accounts payable rose by 102.43% to 1.91 billion yuan, driven by the growth of the discount snack business[7] - Short-term borrowings increased by 60.75% to 821.07 million yuan, reflecting higher working capital needs[7] - Capital reserve grew by 43.60% to 522.85 million yuan, mainly due to equity financing[8] - Minority shareholders' equity surged by 453.08% to 279.02 million yuan, reflecting increased profits from the discount snack business[8] - The company's total assets increased to 6,458,418,402.46 yuan as of September 30, 2024, compared to 3,925,354,361.68 yuan at the beginning of the year, reflecting significant growth[19][20][21] - The company's monetary funds grew to 2,292,794,509.98 yuan, up from 1,209,689,850.18 yuan at the beginning of the year[19] - Inventory increased to 1,787,572,807.31 yuan, compared to 733,288,606.20 yuan at the start of the year[19] - Total liabilities rose to 5,266,424,254.49 yuan, up from 3,229,545,195.69 yuan at the beginning of the year[21] - Shareholders' equity increased to 1,191,994,147.97 yuan, compared to 695,809,165.99 yuan at the start of the year[21] - The company's short-term borrowings increased to 821,071,023.52 yuan, up from 510,765,675.17 yuan at the beginning of the year[20] - Accounts payable grew to 1,909,239,404.42 yuan, compared to 943,174,069.62 yuan at the start of the year[20] Snack Retail Business Performance - The snack retail business generated 20.23 billion yuan in revenue and 392 million yuan in net profit for the first nine months of 2024, with Q3 revenue reaching 9.55 billion yuan and net profit at 201 million yuan[10] - The company's snack retail business saw a significant increase in sales and management expenses, rising by 258.57% and 144.49% respectively, due to business expansion[9] - Income tax expenses surged by 4130.68% to 229.64 million yuan, mainly due to the expansion of the snack retail business[9] - Sales revenue from goods and services reached 23.22 billion yuan, a significant increase from 5.59 billion yuan in the previous period[25] Expenses and Costs - The company's total operating costs reached 20,052,037,551.11 yuan, compared to 5,028,819,170.26 yuan in the same period last year[22] - Sales expenses increased to 894.92 million yuan, up from 249.58 million yuan in the previous period[23] - Management expenses rose to 622.18 million yuan, compared to 254.48 million yuan in the previous period[23] - R&D expenses were 2.98 million yuan, slightly higher than the 2.07 million yuan in the previous period[23] - Financial expenses increased to 28.86 million yuan, up from 18.10 million yuan in the previous period[23] - Interest income was 10.03 million yuan, a significant increase from 1.15 million yuan in the previous period[23] Shareholder and Equity Information - The company granted 770,000 second-class restricted shares to 20 incentive recipients at a price of 15.17 yuan per share on August 15, 2024[16] - The company completed the registration of 2,285,285 restricted shares for 144 incentive recipients, increasing the total share capital from 177,199,647 shares to 179,484,932 shares[17] - The company's largest shareholder, Fujian Mimosa Agricultural Development Co., Ltd., holds 40,949,000 shares, accounting for 23.11% of the total shares[13] - The company's second-largest shareholder, Zhangzhou Jinwanchen Investment Co., Ltd., holds 29,935,000 shares, accounting for 16.89% of the total shares[13] - The company's third-largest shareholder, Peng Dejian, holds 6,777,485 shares, accounting for 3.83% of the total shares[13] - The company's fourth-largest shareholder, Shenzhen Dingxin Enterprise Consulting Management Co., Ltd., holds 3,877,215 shares, accounting for 2.19% of the total shares[13] - The company's fifth-largest shareholder, Shenzhen Weishunzhengxin Investment Co., Ltd., holds 3,718,413 shares, accounting for 2.10% of the total shares[13] - The company's sixth-largest shareholder, China Merchants Bank Co., Ltd. - Orient Red Ruihe Three-Year Regular Open Hybrid Securities Investment Fund, holds 2,095,392 shares, accounting for 1.18% of the total shares[13] - The company's seventh-largest shareholder, China Merchants Bank Co., Ltd. - Orient Red Hengyang Five-Year Regular Open Hybrid Securities Investment Fund, holds 2,037,588 shares, accounting for 1.15% of the total shares[13] - A 7.5% stake in the company, totaling 13,461,370 shares, was transferred between shareholders, with no change in controlling shareholders[18] Investments and Acquisitions - The company plans to acquire 49% equity of Nanjing Wanhao Commercial Management Co., Ltd. for 294 million yuan to optimize industrial resources and enhance competitiveness[17] - The company invested RMB 294.00 million in new investments during the quarter[26] Other Financial Information - The company's other income increased by 569.55% to 40.26 million yuan, mainly due to increased government subsidies[9] - The company's asset disposal losses increased by 439.38% to 8.66 million yuan, primarily due to increased losses from the disposal of non-current assets[9] - The third quarter report was unaudited, as stated by the company's board[27]

国浩律师（北京）事务所 关于 福建万辰生物科技集团股份有限公司 2022 年限制性股票激励计划首次授予部分第二 个归属期及预留授予部分第一个归属期归属条 件成就、部分限制性股票作废事项 之 法律意见书 北京市朝阳区东三环北路 38 号泰康金融大厦 9 层 邮编：100026 9 th Floor, Taikang Financial Tower, No. 38North RoadEast ThirdRing, Chaoyang District, Beijing, 100026, China 电话/Tel: 010-65890699 传真/Fax: 010-65176800 网址/Website: http://www.grandall.com.cn 二〇二四年十月 | 释 义 2 | | --- | | 一、本次归属和本次作废的批准与授权 4 | | 二、本次归属的具体情况 6 | | 三、本次作废的具体情况 10 | | 四、结论意见 10 | 在本《法律意见书》中，除非文义另有所指，下列词语具有下述含义： | 万辰集团、公司 | 指 | 福建万辰生物科技集团股份有限公司 | | --- | --- | ...

证券代码：300972 证券简称：万辰集团 公告编号：2024-098 福建万辰生物科技集团股份有限公司 第四届董事会第二十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 福建万辰生物科技集团股份有限公司（以下简称"公司"）第四届董事会第 二十次会议于 2024 年 10 月 28 日在公司会议室以现场结合通讯方式召开，本次 董事会会议通知于 2024 年 10 月 25 日以书面、电子邮件的形式向公司全体董事 发出。会议应参与表决董事 9 名，实际参与表决董事 9 名，会议由公司董事长王 健坤主持，公司监事和高级管理人员列席会议。本次会议的召开符合《中华人民 共和国公司法》等相关法律法规以及《福建万辰生物科技集团股份有限公司章程》 的规定。 二、董事会会议审议情况 全体与会董事经认真审议，形成以下决议： （一）审议通过《关于公司<2024 年第三季度报告>的议案》 根据相关法律法规、中国证监会和深圳证券交易所的相关规定，公司编制了 《2024 年第三季度报告》，本议案在提交董事会审议前，已经公司董事会审计委 员会审议通 ...